{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:21:34Z","timestamp":1792016494524,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-025-01381-y","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:59:04Z","timestamp":1767779944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Vascular Density\/Angiogenesis Marker CD31\/PECAM1 does not Correlate with Overall Survival in Neuroendocrine Tumors"],"prefix":"10.1007","volume":"57","author":[{"given":"Nicholas J.","family":"Skill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Avanzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Bren-Mattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Philip","family":"Boudreaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramcharan","family":"Thiagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Maluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"1","key":"1381_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5662\/wjm.v12.i1.43","volume":"12","author":"K Kampoli","year":"2022","unstructured":"Kampoli K, et al. Interrogating the interplay of angiogenesis and immunity in metastatic colorectal cancer. World J Methodol. 2022;12(1):43\u201353.","journal-title":"World J Methodol"},{"issue":"1","key":"1381_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00423-023-02823-6","volume":"408","author":"M Akabane","year":"2023","unstructured":"Akabane M, et al. Subserosal vascular density predicts oncological features of T2 gallbladder cancer. Langenbecks Arch Surg. 2023;408(1):73.","journal-title":"Langenbecks Arch Surg"},{"key":"1381_CR3","doi-asserted-by":"publisher","first-page":"772349","DOI":"10.3389\/fendo.2021.772349","volume":"12","author":"M Pereira","year":"2021","unstructured":"Pereira M, et al. Characterizing endocrine Status, tumor hypoxia and immunogenicity for therapy success in epithelial ovarian cancer. Front Endocrinol (Lausanne). 2021;12:772349.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1381_CR4","first-page":"e1779","volume":"6","author":"KK Zajac","year":"2023","unstructured":"Zajac KK, et al. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes. Cancer Rep (Hoboken). 2023;6(1):e1779.","journal-title":"Cancer Rep (Hoboken)"},{"key":"1381_CR5","doi-asserted-by":"publisher","first-page":"102441","DOI":"10.1016\/j.ceb.2024.102441","volume":"91","author":"S Huveneers","year":"2024","unstructured":"Huveneers S, Phng LK. Endothelial cell mechanics and dynamics in angiogenesis. Curr Opin Cell Biol. 2024;91:102441.","journal-title":"Curr Opin Cell Biol"},{"key":"1381_CR6","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jconrel.2023.06.036","volume":"360","author":"S Lv","year":"2023","unstructured":"Lv S, et al. Emerging role of interactions between tumor angiogenesis and cancer stem cells. J Control Release. 2023;360:468\u201381.","journal-title":"J Control Release"},{"key":"1381_CR7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fonc.2019.01399","volume":"9","author":"D Aguilar-Cazares","year":"2019","unstructured":"Aguilar-Cazares D, et al. Contribution of angiogenesis to inflammation and cancer. Front Oncol. 2019;9:1399.","journal-title":"Front Oncol"},{"issue":"5","key":"1381_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1210\/er.2002-0008","volume":"24","author":"HE Turner","year":"2003","unstructured":"Turner HE, et al. Angiogenesis in endocrine tumors. Endocr Rev. 2003;24(5):600\u201332.","journal-title":"Endocr Rev"},{"issue":"2","key":"1381_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5009\/gnl19407","volume":"15","author":"X Zhu","year":"2021","unstructured":"Zhu X, et al. CD31 and D2-40 contribute to peritoneal metastasis of colorectal cancer by promoting Epithelial-Mesenchymal transition. Gut Liver. 2021;15(2):273\u201383.","journal-title":"Gut Liver"},{"issue":"1","key":"1381_CR10","doi-asserted-by":"publisher","first-page":"e54674","DOI":"10.1371\/journal.pone.0054674","volume":"8","author":"H Zhao","year":"2013","unstructured":"Zhao H, et al. Prognostic significance of the combined score of endothelial expression of nucleolin and CD31 in surgically resected non-small cell lung cancer. PLoS One. 2013;8(1):e54674.","journal-title":"PLoS One"},{"issue":"7","key":"1381_CR11","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1007\/s13277-014-1987-9","volume":"35","author":"Y Chen","year":"2014","unstructured":"Chen Y, et al. Expression of basic fibroblast growth factor, CD31, and alpha-smooth muscle actin and esophageal cancer recurrence after definitive chemoradiation. Tumour Biol. 2014;35(7):7275\u201382.","journal-title":"Tumour Biol"},{"issue":"1","key":"1381_CR12","first-page":"82","volume":"7","author":"M Miettinen","year":"1994","unstructured":"Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens\u2013evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;7(1):82\u201390.","journal-title":"Mod Pathol"},{"key":"1381_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12123120","author":"T Annese","year":"2022","unstructured":"Annese T, et al. Differential P-glycoprotein\/CD31 expression as markers of vascular co-option in primary central nervous system tumors. Diagnostics. 2022. https:\/\/doi.org\/10.3390\/diagnostics12123120.","journal-title":"Diagnostics"},{"issue":"19","key":"1381_CR14","first-page":"4082","volume":"20","author":"YM Feng","year":"2016","unstructured":"Feng YM, Chen XH, Zhang X. Roles of PECAM-1 in cell function and disease progression. Eur Rev Med Pharmacol Sci. 2016;20(19):4082\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"1381_CR15","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/CIRCRESAHA.120.315935","volume":"126","author":"G Caligiuri","year":"2020","unstructured":"Caligiuri G. CD31 as a therapeutic target in atherosclerosis. Circ Res. 2020;126(9):1178\u201389.","journal-title":"Circ Res"},{"issue":"2","key":"1381_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000497355","volume":"109","author":"M Cives","year":"2019","unstructured":"Cives M, et al. The tumor microenvironment in neuroendocrine tumors: biology and therapeutic implications. Neuroendocrinology. 2019;109(2):83\u201399.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1381_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.pop.2024.04.010","volume":"51","author":"S Kamboj","year":"2024","unstructured":"Kamboj S, et al. Neuroendocrine Neoplasms Prim Care. 2024;51(3):549\u201360.","journal-title":"Neuroendocrine Neoplasms Prim Care"},{"issue":"1","key":"1381_CR18","first-page":"4","volume":"5","author":"YZ Wang","year":"2016","unstructured":"Wang YZ, et al. Neuroendocrine tumors (NETs) of unknown primary: is early surgical exploration and aggressive debulking justifiable? Chin Clin Oncol. 2016;5(1):4.","journal-title":"Chin Clin Oncol"},{"issue":"4","key":"1381_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2016.12.032","volume":"224","author":"EA Woltering","year":"2017","unstructured":"Woltering EA, et al. Aggressive surgical approach to the management of neuroendocrine tumors: A report of 1,000 surgical cytoreductions by a single institution. J Am Coll Surg. 2017;224(4):434\u201347.","journal-title":"J Am Coll Surg"},{"issue":"8","key":"1381_CR20","first-page":"e67493","volume":"16","author":"S Mukherjee","year":"2024","unstructured":"Mukherjee S, Vagha S, Mukherjee M. Various Markers Neuroendocrine Tumor: Narrative Rev Cureus. 2024;16(8):e67493.","journal-title":"Various Markers Neuroendocrine Tumor: Narrative Rev Cureus"},{"key":"1381_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113645","author":"A Venugopal","year":"2022","unstructured":"Venugopal A, et al. EMT molecular signatures of pancreatic neuroendocrine neoplasms. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232113645.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1381_CR22","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11605-019-04261-6","volume":"24","author":"AG Lopez-Aguiar","year":"2020","unstructured":"Lopez-Aguiar AG, et al. STAT3 Inhibition for Gastroenteropancreatic Neuroendocrine Tumors: Potential for a New Therapeutic Target? J Gastrointest Surg. 2020;24(5):1138\u201348.","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"1381_CR23","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/00000478-200109000-00007","volume":"25","author":"JK McKenney","year":"2001","unstructured":"McKenney JK, Weiss SW, Folpe AL. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol. 2001;25(9):1167\u201373.","journal-title":"Am J Surg Pathol"},{"issue":"4947","key":"1381_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1126\/science.1690453","volume":"247","author":"PJ Newman","year":"1990","unstructured":"Newman PJ, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247(4947):1219\u201322.","journal-title":"Science"},{"issue":"2","key":"1381_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1309\/AJCPRHM8CZH5EMFD","volume":"143","author":"V Vanchinathan","year":"2015","unstructured":"Vanchinathan V, et al. The vascular marker CD31 also highlights histiocytes and histiocyte-like cells within cutaneous tumors. Am J Clin Pathol. 2015;143(2):177\u201385. quiz 305.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"1381_CR26","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1186\/s12885-024-13277-4","volume":"24","author":"T Luan","year":"2024","unstructured":"Luan T, et al. A clinical analysis and literature review of eleven cases with primary pulmonary angiosarcoma. BMC Cancer. 2024;24(1):1597.","journal-title":"BMC Cancer"},{"issue":"9","key":"1381_CR27","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-08-4173","volume":"69","author":"A Zucchetto","year":"2009","unstructured":"Zucchetto A, et al. CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res. 2009;69(9):4001\u20139.","journal-title":"Cancer Res"},{"issue":"5","key":"1381_CR28","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1021\/acs.molpharmaceut.4c00084","volume":"21","author":"Z Chen","year":"2024","unstructured":"Chen Z, et al. Enhanced theranostic efficacy of (89)Zr and (177)Lu-Labeled Aflibercept in renal cancer: A viable option for clinical practice. Mol Pharm. 2024;21(5):2544\u201354.","journal-title":"Mol Pharm"},{"issue":"5","key":"1381_CR29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s00259-023-06575-9","volume":"51","author":"Q Yang","year":"2024","unstructured":"Yang Q, et al. Theranostic role of (89)Zr- and (177)Lu-labeled Aflibercept in breast cancer. Eur J Nucl Med Mol Imaging. 2024;51(5):1246\u201360.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1381_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12876-021-01705-9","volume":"21","author":"A Venugopal","year":"2021","unstructured":"Venugopal A, et al. mRNA profiling of a well-differentiated G1 pancreatic NET correlates with immunohistochemistry profile: a case report. BMC Gastroenterol. 2021;21(1):194.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"1381_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/jcp.43.9.752","volume":"43","author":"DV Parums","year":"1990","unstructured":"Parums DV, et al. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 1990;43(9):752\u20137.","journal-title":"J Clin Pathol"},{"issue":"9","key":"1381_CR32","doi-asserted-by":"publisher","first-page":"p1651","DOI":"10.1038\/s41379-021-00825-7","volume":"34","author":"IA Cree","year":"2021","unstructured":"Cree IA, et al. Counting mitoses: SI(ze) matters! Mod Pathol. 2021;34(9):p1651\u20131657.","journal-title":"Mod Pathol"},{"issue":"6","key":"1381_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.32074\/1591-951X-900","volume":"115","author":"SL Renne","year":"2023","unstructured":"Renne SL. How to measure your microscope\u2019s HPF. A critical guide for residents. Pathologica. 2023;115(6):302\u20137.","journal-title":"Pathologica"},{"key":"1381_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-230X(09)03002-4","volume":"103","author":"I Cuevas","year":"2009","unstructured":"Cuevas I, Boudreau N. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds. Adv Cancer Res. 2009;103:25\u201342.","journal-title":"Adv Cancer Res"},{"issue":"1","key":"1381_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10238-024-01366-4","volume":"24","author":"G Cazzato","year":"2024","unstructured":"Cazzato G, et al. Mast cell density in Merkel cell carcinoma and its correlation with prognostic features and MCPyV status: a pilot study. Clin Exp Med. 2024;24(1):151.","journal-title":"Clin Exp Med"},{"issue":"9","key":"1381_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","volume":"4","author":"D Greenbaum","year":"2003","unstructured":"Greenbaum D, et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 2003;4(9):117.","journal-title":"Genome Biol"},{"key":"1381_CR37","unstructured":"FOUNDATION N. Neuroendocrine neoplasms outcomes. Online; 2025."},{"issue":"1","key":"1381_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nm976","volume":"10","author":"T Wang","year":"2004","unstructured":"Wang T, et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med. 2004;10(1):48\u201354.","journal-title":"Nat Med"},{"issue":"1","key":"1381_CR39","first-page":"14","volume":"22","author":"M Omrani","year":"2025","unstructured":"Omrani M, Basiri A, Rahimlou M. Impact of positive surgical margins on recurrence and overall survival following partial nephrectomy: a systematic review and meta-analysis. Urol J. 2025;22(1):14\u201324.","journal-title":"Urol J"},{"issue":"1","key":"1381_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12029-017-0014-y","volume":"50","author":"SY Mohamed","year":"2019","unstructured":"Mohamed SY, et al. Role of VEGF, CD105, and CD31 in the prognosis of colorectal cancer cases. J Gastrointest Cancer. 2019;50(1):23\u201334.","journal-title":"J Gastrointest Cancer"},{"key":"1381_CR41","doi-asserted-by":"crossref","unstructured":"Chen SY et al. ST6GAL1-Mediated sialylation of PECAM-1 promotes a transcellular Diapedesis-Like process that directs lung tropism of metastatic breast cancer. Cancer Res, 2024.","DOI":"10.1158\/0008-5472.28721751"},{"key":"1381_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184471","author":"CA Cella","year":"2022","unstructured":"Cella CA, et al. Addressing the role of angiogenesis in patients with advanced pancreatic neuroendocrine tumors treated with everolimus: a biological prospective analysis of soluble biomarkers and clinical outcomes. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14184471.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1381_CR43","doi-asserted-by":"publisher","first-page":"e0245602","DOI":"10.1371\/journal.pone.0245602","volume":"16","author":"MP Labrecque","year":"2021","unstructured":"Labrecque MP, et al. Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature. PLoS ONE. 2021;16(1):e0245602.","journal-title":"PLoS ONE"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01381-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01381-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01381-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:02:49Z","timestamp":1767823369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01381-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1381"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01381-y","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"20 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved Louisiana State University Institutional review board. #8460. Study was determined to be not human research. No intervention was performed, and patient data was deidentified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable. This manuscript does not contain individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}